CCL2 and rheumatoid arthritis: The in vitro treatment of monocytes with SLE and RA serum before RTX treatment promoted increased expression of pro‐thrombotic and pro‐inflammatory molecules (TF, VEGF, MCP‐1, IL‐8, IL‐1ß).